Learn more

VELICO MEDICAL INC

Overview
  • Total Patents
    98
  • GoodIP Patent Rank
    79,542
  • Filing trend
    ⇩ 83.0%
About

VELICO MEDICAL INC has a total of 98 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, chemical engineering and basic materials chemistry are CYTONET GMBH & CO KG, HARIRI ROBERT J and ANTHROGENESIS CORP.

Patent filings per year

Chart showing VELICO MEDICAL INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Liu Qiyong Peter 38
#2 Rosiello Keith 20
#3 Clausen Henrik 19
#4 Haley Michael 17
#5 Sackstein Robert 14
#6 Hoffmeister Karin 12
#7 Khan Abdul Wahid 10
#8 Clausen Henrick 10
#9 Perivolotis George T 9
#10 Rosenfelder John Charles 9

Latest patents

Publication Filing date Title
US2017370952A1 Reconstitution Solution for Spray-Dried Plasma
WO2017177104A1 Reconstitution solution for spray-dried plasma
US2016143269A1 Platelet protection solution having beta-galactosidase and sialidase inhibitors
US2016145573A1 Platelet Protection Solution Having a Beta-Galactosidase Inhibitor
US2016000064A1 Platelet Storage and Reduced Bacterial Proliferation in Platelet Products Using a Sialidase Inhibitor
US2016082043A1 Methods and systems for multi-stage drying of plasma
WO2014120886A1 Platelet additive solution having a self-assembling hydrogel-forming peptide
CA2887083A1 Platelet additive solution having a beta-galactosidase inhibitor
US2014083628A1 Spray drier assembly for automated spray drying
US2014083627A1 Automated spray drier
US2013078324A1 Spray dried human plasma
AU2012233042A1 Blood processing device and associated systems and methods
WO2012158983A2 Platelet storage using a sialidase inhibitor
AU2012202553A1 Enzymatic Conversion of Blood Group A, B, and AB Red Blood Cells using a-N-Acetylgalactosaminidases a-Galactosidases with unique substrate specificities and kinetic properties
AU2011320528A1 System and method for spray drying a liquid
AU2011203365A1 Expandable processing and expression chamber
WO2011035062A2 Spray dried human plasma
EP2502492A2 Novel alpha-galactosidases
AU2013203945A1 Novel alpha-galactosidases
EP2250883A2 Novel alpha-galactosidases